Iain Gardner
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
Papers in
- Pharmacology 35
- Pharmacogenetics and Drug Metabolism 32
- Antibiotics Pharmacokinetics and Efficacy 8
- Drug-Induced Hepatotoxicity and Protection 7
- Co-authors
- Kevin BeaumontRobert WebsterKevin N. DackMiroslav DostálekMasoud JameiHannah M. JonesBrian M. GurbaxaniKenny J. Watson
- Journals
- The AAPS Journal (7 papers)CPT Pharmacometrics & Systems Pharmacology (6 papers)Drug Metabolism and Disposition (6 papers)Xenobiotica (5 papers)Archives of Toxicology (5 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Iain Gardner
79 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 135
- Pharmacology 765
- Pharmaceutical Science 199
- Computational Theory and Mathematics 375
- Biological Psychiatry 42
- Pharmacology 269
Countries citing papers authored by Iain Gardner
This map shows the geographic impact of Iain Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain Gardner more than expected).
Fields of papers citing papers by Iain Gardner
This network shows the impact of papers produced by Iain Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain Gardner. The network helps show where Iain Gardner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iain Gardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 5 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 32 | |
| 14 | 2021 | 45 | |
| 15 | 2021 | 49 | |
| 16 | 2021 | 11 | |
| 17 | 2020 | 26 | |
| 18 | 2020 | 18 | |
| 19 | 2013 | 55 | |
| 20 | 2013 | 184 |
About Iain Gardner
Iain Gardner is a scholar working on Pharmacology, Biological Psychiatry, Pharmaceutical Science, Oncology and Hepatology, having authored 94 papers that have together received 2.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (32 papers), Drug Transport and Resistance Mechanisms (17 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Analytical Chemistry and Chromatography (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Protein purification and stability (5 papers) and Computational Drug Discovery Methods (5 papers). The work is most often cited by research in Pharmacology (765 citations), Pharmaceutical Science (199 citations), Computational Theory and Mathematics (375 citations), Biological Psychiatry (42 citations) and Pharmacology (269 citations). Iain Gardner has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Kevin Beaumont, Robert Webster, Kevin N. Dack, Miroslav Dostálek, Masoud Jamei, Hannah M. Jones, Brian M. Gurbaxani, Kenny J. Watson, Jack Uetrecht and Nasir Zahid. Their work appears in journals such as The AAPS Journal, CPT Pharmacometrics & Systems Pharmacology, Drug Metabolism and Disposition, Xenobiotica and Archives of Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.